Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 7, 2013, Pages 847-852

  Lindenburg, I T M ^a   Van Kamp, I L ^a   Van Zwet, E W ^a   Middeldorp, J M ^a   Klumper, F J C M ^a   Oepkes, D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloimmune anaemia; early intrauterine transfusion; fetal hydrops; fetal therapy; red cell alloimmunisation

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN ZETA CHAIN;

ARTICLE; BLOOD GROUP KELL SYSTEM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETAL THERAPY; FETUS; FETUS HYDROPS; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PERINATAL DEATH; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC; BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL MORTALITY; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; INFANT MORTALITY; INFANT, NEWBORN; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PERINATAL MORTALITY; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84877755686     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12063     Document Type: Article

References (26)

1. Rodeck CH, Kemp JR, Holman CA, Whitmore DN, Karnicki J, Austin MA,. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation. Lancet 1981; 1: 625-7.
2. Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192: 171-7.
3. Moise KJ Jr,. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008; 112: 164-76.
4. Tiblad E, Kublickas M, Ajne G, Bui TH, Ek S, Karlsson A, et al. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther 2011; 30: 266-73.
5. Schumacher B, Moise KJ Jr,. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996; 88: 137-50.
6. Yinon Y, Visser J, Kelly EN, Windrim R, Amsalem H, Seaward PG, et al. Early intrauterine transfusion in severe red blood cell alloimmunization. Ultrasound Obstet Gynecol 2010; 36: 601-6.
7. Johnstone-Ayliffe C, Prior T, Ong C, Regan F, Kumar S,. Early procedure related complications of fetal blood sampling and intrauterine transfusion for fetal anemia. Acta Obstet Gynecol Scand 2012; 91: 458-62.
8. Van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001; 185: 668-73.
9. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL,. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992; 79: 390-3.
10. Van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH,. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands 1988-1999. Acta Obstet Gynecol Scand 2004; 83: 731-7.
11. Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR,. The management of severe rhesus isoimmunisation by fetoscopic intravascular transfusion. Am J Obstet Gynecol 1984; 150: 769-74.
12. Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibashan RS, Campbell S,. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988; 14: 1073-5.
13. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM,. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247-52.
14. Weiner CP, Widness JA,. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547-51.
15. Liley AW,. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963; ii: 1107-9.
16. Bennebroek Gravenhorst J, Kanhai HH, Meerman RH, Ruys JH, Eernisse JG, Stroes TJ, et al. Twenty-two years of intra-uterine intraperitoneal transfusions. Eur J Obstet Gynecol Reprod Biol 1989; 33: 71-7.
17. Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD,. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fetal Diagn Ther 2008; 28: 159-63.
18. Clarke CA, Elson CJ, Bradley J, Donohoe WT, Lehane D, Hughes-Jones NC,. Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women. Lancet 1970; 1: 793-8.
19. Dau PC,. Immunologic rebound. J Clin Apher 1995; 10: 210-7.
20. Berlin G, Selbing A, Ryden G,. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1985; 1: 1153.
21. De la Cámara C, Arrieta R, González A, Iglesias E, Omeñaca F,. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988; 318: 519-20.
22. Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR,. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997; 52: 193-7.
23. Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M,. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997; 25: 85-8.
24. Fernández-Jiménez MC, Jiménez-Marco MT, Hernández D, González A, Omeñaca F, de la Cámara C,. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang 2001; 80: 117-20.
25. Ruma SR, Moise KJ Jr, Eunhee K, Murtha AP, Prutsman WJ, Hassan SS, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007; 196:138. e1-6.
26. Lindenburg ITM, Smits-Wintjens VEHJ, van Klink JMM, Verduin E, Van Kamp IL, Walther FJ, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn; the LOTUS study. Am J Obstet Gynecol 2012; 206:141. e1-8.